C12Y 302/01123
Endoglycosylceramidase
Official title: Endoglycosylceramidase (3.2.1.123)
C12Y302/01123 (Endoglycosylceramidase) appears on 4 US grants and 8 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 8
- Assignees
- 7
- Inventors
- 23
- Latest grant
- 21 May 2019
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 2 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 0 |
| 2016 | 0 | 1 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 1 |
| 2021 | 0 | 0 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Mutant endoglycoceramidases with enhanced synthetic activity21 May 2019US 10,294,504 B2La Jolla Pharmaceutical Company
- Mutant endoglycoceramidases with enhanced synthetic activity30 Jun 2015US 9,068,208 B2Seneb Biosciences, Inc.
- Gene encoding endoglycoceramidase18 Aug 1998US 5,795,765 ATakara Shuzo Co., Ltd.
- Ceramide-glycanase10 Sep 1991US 5,047,337 A
- Novel glycosynthase20 Nov 2025US 2025/0354131 A1
- Mutant endoglycoceramidases with enhanced synthetic activity23 Jan 2020US 2020/0024628 A1
- Mutant Endoglycoceramidases with Enhanced Synthetic Activity4 Feb 2016US 2016/0032342 A1Seneb Biosciences, Inc.
- Mutant endoglycoceramidases with enhanced synthetic activity29 May 2014US 2014/0147891 A1Seneb Biosciences, Inc.
- Solvents for mutant endoglycoceramidases with synthetic activity9 Jul 2009US 2009/0176278 A1Neose Technologies, Inc.
Most cited
By later US patents